Alembic Pharmaceuticals Head of International Business Resigns

Alembic Pharmaceuticals announces the resignation of Mr. Prashant Khandelwal, Head-International Business Formulations, effective December 1, 2025, after the close of business hours. The resignation was tendered on September 1, 2025. Mr. Khandelwal served a three-month notice period. The company has released details related to the resignation as per standard disclosure requirements.

Executive Departure

Alembic Pharmaceuticals has announced that Mr. Prashant Khandelwal, who held the position of Head-International Business Formulations, has resigned from his role. The effective date of his resignation is December 1, 2025, after business hours.

Resignation Details

Mr. Khandelwal’s resignation was submitted on September 1, 2025. He served a standard three-month notice period before his departure. No further details regarding the reasons for his resignation or future plans have been disclosed in the company’s announcement.

Impact and Next Steps

The company has not yet announced a replacement for the Head-International Business Formulations position. Further announcements regarding the leadership transition are expected in the coming weeks. The announcement complies with standard disclosure norms.

Source: BSE

InvestyWise News
InvestyWise News
Covers market-moving news with speed and precision, delivering sharp insights to help readers stay ahead in the fast-paced world of stocks.

Latest articles

Related articles

Leave a reply

Please enter your comment!
Please enter your name here
Captcha verification failed!
CAPTCHA user score failed. Please contact us!